Zarzio 30 MU/0.5 ml
Zarzio 30 MU/0.5 ml is a medicine authorised by Swissmedic under authorisation number 60579. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 February 2010 and the authorisation is valid without a time limit. ATC code L03AA02 places the medicine in the group Immunostimulants.
| Authorisation number | 60579 |
|---|---|
| Name | Zarzio 30 MU/0.5 ml |
| Full name | Zarzio 30 MU/0.5 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L03AA02 |
| First authorisation | 12 February 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zarzio 30 MU/0.5 ml, Injektionslösung in einer Fertigspritze | A | 12 February 2010 |
| 2 | Zarzio 48 MU/0.5 ml, Injektionslösung in einer Fertigspritze | A | 12 February 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Spritze(n) | L03AA02 | 06.07.3. | A |
| 2 | 5 | Spritze(n) | L03AA02 | 06.07.3. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zarzio 30 MU/0.5 ml authorised in Switzerland?
Yes. Zarzio 30 MU/0.5 ml is authorised by Swissmedic under authorisation number 60579, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zarzio 30 MU/0.5 ml have?
Zarzio 30 MU/0.5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Zarzio 30 MU/0.5 ml?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.